Clinical evidence dossier
Insulin therapy
HbA1c
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 4
- Supporting studies available for review
- 4
- Randomized trials
- 4
- Reported effects
- 5
Clinical conclusion
Insulin therapy shows a strong positive evidence signal for improving HbA1c across the studied comparisons.
Observed effects
Observed study estimates; not a pooled treatment effect.
Between-group effect
Absolute change
-0.5 to -0.5 %
Change from baseline
Mean difference
-0.71 to -0.71 %
Between-group effect
Mean difference
-0.9 to 0 %
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 4
Consistency
Authoritative consistency classification
consistent
- Positive
- 3
- No effect
- 1
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 4 of 4 supporting studies. 4 studies described participants with type 2 diabetes. 4 studies described adult participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults with type 2 diabetes currently on insulin therapy.
- Patients seeking improved glycemic control and reduced hypoglycemia.
- Adults diagnosed with Type 2 diabetes.
- Patients requiring insulin therapy.
- Individuals seeking improved diabetes management strategies.
- Elderly patients aged 65 and older with type 2 diabetes.
- Patients requiring insulin therapy for diabetes management.
- Adults diagnosed with type 2 diabetes
- Patients currently on premixed insulin therapy
Limitations
- Evidence uses heterogeneous comparison contexts: active_comparator, usual_care.
- 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.